Targeted maintenance therapy for a young woman with cervical rhabdomyosarcoma: A case report and review of literature

Table 2 Case reports

Ref.	Design, n	Age	Side	Stage	Surgery	Chemotherapy	Radiotherapy	Recurrence	Vital status (months)
Gruessner et al[16], 2004	Case report	5	Cervix	IA	Polypectomy	VAC	No	No	39/NED
Scaravilli et al[17], 2009	Case report	35	Cervix	I1	Total laparohysterectomy with bilateral annessiectomy and pelvic lymphadenectomy	Cysplatinum, adriamycin and dacarbazin + vincristine and actinomycin	No	No	12+/NED
Koukourakis et al[18], 2009	Case report	20	Cervix	IIA	Radical hysterectomy, upper vaginectomy and bilateral pelvic lymphadenectomy were performed	Ifosfamide + etoposide + cisplatin	Yes	No	3/NED
Ocheke et al[19], 2011	Case report	16	Cervix	Unkonwn	Polypectomy	No	No	Yes	6/Died
Karaman et al[20], 2011	Case report	22	Cervix	IA	Conization	VAC	No	No	18/NED
Melo et al[21], 2012	Case report	20	Cervix	IA	Radical surgery	Ifosfamide vincristine actinomycin	No	No	36/NED
Xu et al[22], 2022	Case report	39	Cervix	IB3	Laparoscopic radical hysterectomy, bilateral salpingo-oophrectomy and pelvic lymph node dissection	VAC	No	No	49/NED
Pop et al[7], 2023	Case report	46	Cervix	IA1	C1-type hysterectomy	vincristine ifosfamide doxorubicin etoposide and CHT	Yes	Yes	60/NED

VAC: Vincristine, actinomycin D, and cyclophosphamide; NED: No evidence of disease; CHT: Chemotherapy.